Background: Sepsis is a serious complication in surgical patients, and is associated with prolonged hospital stay and high mortality rates. The definitions of sepsis have been revisited recently. This article reviews how definitions have changed over the years, and provides an update on basic pathobiology and essential aspects of treatment. 
Introduction
Sepsis is a serious complication in surgical patients, and is associated with prolonged hospital stay and high mortality rates. A recent survey 1 of all surgical patients at one academic medical centre in the USA reported that sepsis developed in 3⋅8 per cent of the more than 25 500 patients who underwent surgery over a 3⋅5-year interval. Rates of sepsis were highest among patients who had cardiothoracic and trauma surgery. As with sepsis in other groups of patients 2 , the lungs, bloodstream and abdomen were the most common sites of infection 1 . In a retrospective study 3 of elective surgical admissions across New South Wales between 2002 and 2009, the incidence of sepsis increased from 12⋅7 to 15⋅8 per cent per 1000 admissions. The mortality rate of patients with surgical sepsis in 2009 was 20⋅2 per cent 3 . Many surgical patients who develop sepsis are admitted to an ICU. In a study 4 of all surgical patients admitted to the ICU in one hospital, 25 per cent developed sepsis and these patients had a higher mortality rate than un-infected patients. In an analysis of 231 surgical patients with sepsis in one ICU, 26 per cent had septic shock, which was associated with a mortality rate of 36 per cent 5 .
Sepsis definitions
The condition of sepsis has been recognized for centuries ( Fig. 1 ) and yet there is still debate about how best to define it. Part of the problem has been the confusion between the words infection and sepsis. Infection is a microbiological phenomenon associated with a local and sometimes mild systemic host response. Sepsis develops when that host response is dysregulated. Although obviously related, the two words do not have the same meaning; a patient with sepsis by definition has an infection, but the reverse is not always true. They cannot be used interchangeably. inside the body. Later, it was believed that sepsis, and indeed other disease, was the result of decaying matter present in miasma, a smog-like air characterized by its bad smell. Indeed, the Roman writer, Marcus Terentius Varro, writing in about 100 BC, even suggested there might be micro-organisms present in the miasma: 'certain minute creatures which cannot be seen by the eyes, but which float in the air and enter the body through the mouth and nose and cause serious diseases' 7 . The 'minute creatures' were first visualized by van Leeuwenhoek 8 in 1674 using a home-made microscope. However, it was not until some 200 years later that the actual link between these micro-organisms and sepsis really began to be made, with the findings of Semmelweiss, Lister, Pasteur and Koch, among others 6 . Finally, in 1914, Schottmüller proposed for the first time that sepsis was related to the host's response to infection, stating that sepsis was present 'if a focus has developed from which pathogenic bacteria, constantly or periodically, invade the blood stream in such a way that this causes subjective and objective symptoms' 9 .
Consensus conferences
With the development of ICUs and advances in immunology, the focus of the definition of sepsis became the host response. The American College of Chest Physicians/Society of Critical Care Medicine (SCCM/ACCP) consensus conference held in 1991 tried to quantify that response. The participants defined sepsis as the presence of infection plus at least two of the systemic inflammatory response syndrome (SIRS) criteria: temperature above 38 ∘ C or below 36 ∘ C; heart rate more than 90 beats per min; respiratory rate over 20 breaths per min or arterial partial pressure of carbon dioxide less than 32 mmHg; and white blood cell count over 12 000/mm 3 , less than 4000/mm 3 , or more than 10 per cent immature (band) forms 10 . However, the vast majority of patients with infection have at least two SIRS criteria, so the definition effectively suggested that sepsis was simply equivalent to infection 11 . Moreover, the SIRS criteria are too sensitive to be helpful. In the ICU, some 90 per cent of patients meet the SIRS criteria 12, 13 . Even on general hospital wards, as many as 50 per cent of patients may have at least two SIRS criteria at one time or another 14 .
With these concerns regarding the SIRS criteria for defining sepsis, a second consensus conference was held in 2001 15 . The participants attempted to develop an alternative to SIRS that was more specific for infection, but the expanded list of signs and symptoms was too long to be useful in clinical practice.
In 2014, a task force of 19 critical care, infectious disease, surgical and pulmonary specialists was charged with establishing a new definition that would be accepted widely and implemented universally. The results of their discussions were published earlier this year 16 . In the definition, the task force has moved away from the association between infection and inflammation, and completely abandoned the SIRS criteria. It has rather returned to a more clinical definition, so that sepsis is now considered as 'life-threatening organ dysfunction caused by a dysregulated host response to infection' 16 . This definition corresponds more closely to the clinician's idea of sepsis and indeed to how the term sepsis has always been used in practice 17 : an infected patient is considered to have sepsis only when there are clinically apparent signs of associated organ dysfunction. If one needs to quantify it, organ dysfunction can be defined using a sequential organ function assessment (SOFA) score 18 of at least 2 for the organ system in question (respiratory, cardiovascular, neurological, coagulation, hepatic and renal). Septic shock is defined as sepsis with ' … profound circulatory, cellular, and metabolic abnormalities (that) are associated with a greater risk of mortality than with sepsis alone'. It can be identified clinically by a need for vasopressor administration to maintain mean arterial BP, associated with serum lactate concentrations higher than 2 mmol/l in the absence of obvious hypovolaemia.
Pathobiology of sepsis
There are still many aspects of this complex response that remain unclear or undiscovered, and new advances are being made on a regular basis as research continues to recognize new molecules and pathways, and to assign new roles to mediators that have already been identified. How sepsis affects individual cells and organ systems, and the interactions among these, is also becoming better defined, and has key implications for the development of future treatments.
Essentially, the sepsis response is triggered by an invading pathogen, usually of bacterial origin but also viral or fungal, or a pathogen-produced substance, such as endotoxin, called a pathogen-associated molecular pattern. These bind to pattern recognition receptors (PRRs) present on macrophages, polymorphonuclear and endothelial cells to initiate the release of proinflammatory mediators that cause vasodilatation and changes in endothelial cell function resulting in altered blood flow distribution, increased vascular permeability and tissue oedema in an attempt to limit the spread of the infection. Coagulation, complement and contact systems are also activated, further promoting the inflammatory response. Endogenous danger-associated molecular patterns (such as heat-shock proteins) are also released and interact with PRRs to promulgate the inflammatory response.
For reasons not yet fully elucidated, but including genetic and other host factors and bacterial virulence, the initially useful response to infection sometimes becomes dysregulated, leading to widespread systemic effects with tissue damage and organ dysfunction -that is sepsis. Various risk factors for sepsis have been identified in surgical patients, and include older age, emergency surgery (compared with elective) and the presence of co-morbid conditions 4, 19, 20 .
Cardiovascular changes associated with sepsis typically include an increase in heart rate and cardiac output, and a decrease in mean arterial BP and systemic vascular resistance, reflecting a fall in vascular tone. Myocardial depression is also frequently present, even when cardiac output is not decreased, and is associated with worse outcomes. Renal changes can lead to acute kidney injury, and altered consciousness can reflect septic encephalopathy. Sepsis-induced coagulopathy is characterized by disseminated intravascular coagulation. Although difficult to detect in humans, altered gut barrier function exists and may lead to increased bacterial translocation and release of other gut-related factors that further stimulate the immune response. Importantly, the altered microcirculation contributes to organ dysfunction, and persistent changes are associated with worse outcomes 21 . New techniques to visualize and monitor the microcirculation will help define therapies that may influence the microcirculation to improve resuscitation and limit organ dysfunction.
Strategies for prevention and treatment

Prevention
As sepsis develops from infection, strategies to prevent infection can help reduce the occurrence of sepsis. General strategies for prevention of nosocomial infections must be applied rigorously, including hand-washing 22 . In the surgical patient, particular attention needs to be paid to preoperative preparation and surgical technique 23 . Surgical-site infections are one of the most common types of nosocomial infection and deep-space surgical-site infection is associated with a greater risk of sepsis 20, 24 . Perioperative prophylactic antibiotics for patients at risk of surgical-site infection should be used appropriate to the surgical procedure, local microbiological patterns and published recommendations 23, 25, 26 . The use of vaccines against specific organisms, such as staphylococci and Pseudomonas aeruginosa, is presently being studied in clinical trials. Given the possible role of the gut in the development of sepsis, it is considered important that normal gut function be maintained during and after surgery. Prolonged preoperative fasting is no longer recommended and starting enteral feeding as soon as possible after surgery is Surgical sepsis syndrome e37 encouraged 27 . Similarly, excessive opioid administration slows bowel function and excessive fluid administration can cause bowel oedema, and should be avoided.
Treatment
There are no specific immunomodulatory therapies available for sepsis, despite multiple avenues of research and many clinical trials. The treatment of sepsis (surgical or medical) is therefore currently based on adequate source control, appropriate antibiotic therapy and organ support. Moderate doses of corticosteroids are sometimes used for their immunomodulatory actions in patients with severe septic shock, but this approach remains under debate 28 . Increasingly, patients who need active resuscitation for sepsis are being managed by dedicated sepsis teams, which include specifically trained nurses and intensivists. These teams ensure that multiple aspects of initial resuscitation are performed simultaneously, saving time and maximizing the chances of survival without complications.
Source control
Source control includes removal of any infected catheters or drains, surgical debridement or removal of infected wounds, tissues or organs, drainage of abscesses and resection of ischaemic bowel.
Antibiotic therapy
Adequate and appropriate antibiotic therapy should be started as soon as possible in patients with sepsis. Ideally, appropriate cultures should be taken first for microbiological evaluation, but this process should not delay the start of antibiotics in severe cases. Gram stain may not provide all the information needed for bacterial identification, and cultures can take several days for results to become available. Therefore, because it is important that the initial antibiotic is effective against the infecting micro-organism(s) 29, 30 , empirical antibiotics are generally broad-spectrum, covering all possible causative agents, and selected based on likely source of infection, local microbiological flora and resistance patterns, recent antimicrobial therapy and type of surgery. Input from an infectious disease specialist (or a clinical microbiologist) is useful, if available. More rapid non-culture-dependent methods of identifying infecting micro-organisms may help better target initial antibiotic choices in the future 31 . Once culture results become available, the choice of antibiotic should be re-evaluated and adjusted to a narrower spectrum if possible, thus ensuring efficacy, while preventing development of resistance, limiting toxicity and reducing costs 32 . However, in patients with negative cultures, as occurs in as many as 30 per cent of patients with sepsis 2, 33 , it may be considered wiser to continue with broad-spectrum antibiotics. Importantly, in addition to the appropriate antibiotic, issues of dose and duration must be considered 34 . These will be influenced by the specific causative micro-organism and severity of disease, as well as by the presence of organ dysfunction and use of certain therapies, such as haemodialysis/haemofiltration, that can alter antibiotic distribution and clearance. Measurement of antibiotic concentrations may be useful in hospitals where this is feasible.
Organ support
Cardiovascular dysfunction is often present in patients with sepsis and requires aggressive fluid therapy, sometimes combined with vasopressor administration. Current guidelines 34 recommend use of crystalloids as the first-choice fluid for initial resuscitation, with addition of albumin when large amounts of crystalloid are required. Hydroxyethyl starch solutions are no longer recommended in sepsis. In patients with septic shock, use of vasopressors should be considered early to limit the duration of hypotension; noradrenaline (norepinephrine) is the vasopressor of choice in these patients 34 -36 . Low doses of dobutamine (approximately 5 μg per kg per min) are often also given to increase cardiac output.
In the patient with septic shock, the speed with which appropriate treatment is initiated is crucial. Treatments can be stopped or decreased as the patient's condition improves, guided by the SOSD (Salvage, Optimization, Stabilization, De-escalation) mnemonic ( Table 1) 37 .
At all times, adequate oxygenation must be ensured; intubation should be performed and mechanical ventilation started if there is any concern about the adequacy of oxygen administration by facial mask or nasal prongs.
Other organ support that may be necessary includes renal replacement therapy, platelet infusion, nutritional support and glucose control. All other aspects of routine management for critically ill patients must also not be forgotten 34 .
The future
The search for new immunomodulatory drugs is continuing as new potential targets are identified. Much of the early focus of immunomodulatory therapies was on limiting or blocking the proinflammatory response, but it is now realized that many patients with sepsis rapidly acquire some form of immunosuppression, and an anti-inflammatory agent may worsen their condition. In these patients, an immunostimulating agent may be beneficial. Moreover, the inflammatory response in each individual may vary over time, necessitating different therapies. Given the heterogeneous nature of patients with sepsis, there is, therefore, unlikely to be one agent that is effective in all. Rather than testing interventions in all patients with sepsis, as has been done so often in the past 39 , future trials must be more selective and include only patients who are likely to respond to the drug in question 40 . With improved genomic, proteomic, immunological and metabolomic patient profiling, it will be increasingly possible to target current and new therapies more appropriately, as already suggested for corticosteroid use 41 . Some promising interventions currently undergoing phase III clinical trials include thrombomodulin 42 , selepressin 43 and alkaline phosphatase 44 .
Conclusion
New definitions of sepsis have retuned the focus to clinical findings in this syndrome and highlighted the importance of organ dysfunction as a key diagnostic feature. Indeed, unexplained acute organ failure in a critically ill patient should raise suspicion of possible sepsis. Use of the SIRS definition led to an increase in the number of cases and a decrease in the number of deaths, because less severe cases were being included in the statistics 45 . With the current definitions abandoning the SIRS criteria, a reversal in these trends can be anticipated, with a decrease in the number of cases, but an increase in mortality rates, which will represent a return to a more accurate reflection of the real situation.
The worldwide burden of sepsis is considerable. Rapid, appropriate source control, appropriate antibiotics and organ support can help maximize the chances of survival. Improved classification of patients according to their specific sepsis profile will enable more personalized therapies.
Disclosure
The author declares no conflict of interest.
